| Gene Symbol | TGFB2 |
| Entrez ID | 7042 |
| Uniprot ID | P61812 |
| Description | transforming growth factor beta 2 |
| Chromosomal Location | chr1: 218,346,235-218,444,619 |
| Ontology | GO ID | GO Term | Definition | Evidence |
|---|---|---|---|---|
|
BP |
GO:0000902 |
cell morphogenesis |
The developmental process in which the size or shape of a cell is generated and organized. |
IDA |
|
BP |
GO:0001501 |
skeletal system development |
The process whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure. The skeleton is the bony framework of the body in vertebrates (endoskeleton) or the hard outer envelope of insects (exoskeleton or dermoskeleton). |
ISS |
|
BP |
GO:0001502 |
cartilage condensation |
The condensation of mesenchymal cells that have been committed to differentiate into chondrocytes. |
IEA |
|
BP |
GO:0001525 |
angiogenesis |
Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels. |
TAS |
|
BP |
GO:0001654 |
eye development |
The process whose specific outcome is the progression of the eye over time, from its formation to the mature structure. The eye is the organ of sight. |
IDA |
|
BP |
GO:0001666 |
response to hypoxia |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level. |
IMP |
|
BP |
GO:0001822 |
kidney development |
The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and/or excretes the end products of body metabolism in the form of urine. |
ISS |
|
BP |
GO:0001837 |
epithelial to mesenchymal transition |
A transition where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell. |
IDA|TAS |
|
BP |
GO:0001843 |
neural tube closure |
The last step in the formation of the neural tube, where the paired neural folds are brought together and fuse at the dorsal midline. |
ISS |
|
BP |
GO:0001942 |
hair follicle development |
The process whose specific outcome is the progression of the hair follicle over time, from its formation to the mature structure. A hair follicle is a tube-like opening in the epidermis where the hair shaft develops and into which the sebaceous glands open. |
IDA|ISS |
|
BP |
GO:0001974 |
blood vessel remodeling |
The reorganization or renovation of existing blood vessels. |
IEA |
|
BP |
GO:0002576 |
platelet degranulation |
The regulated exocytosis of secretory granules containing preformed mediators such as histamine and serotonin by a platelet. |
TAS |
|
BP |
GO:0003007 |
heart morphogenesis |
The developmental process in which the heart is generated and organized. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood. |
IDA |
|
BP |
GO:0003148 |
outflow tract septum morphogenesis |
The process in which the anatomical structures of the outflow tract septum are generated and organized. The outflow tract septum is a partition in the outflow tract. |
ISS |
|
BP |
GO:0003149 |
membranous septum morphogenesis |
The process in which the membranous septum is generated and organized. The membranous septum is the upper part of ventricular septum. |
ISS |
|
BP |
GO:0003179 |
heart valve morphogenesis |
The process in which the structure of a heart valve is generated and organized. |
ISS |
|
BP |
GO:0003181 |
atrioventricular valve morphogenesis |
The process in which the structure of the atrioventricular valve is generated and organized. |
ISS |
|
BP |
GO:0003184 |
pulmonary valve morphogenesis |
The process in which the structure of the pulmonary valve is generated and organized. |
ISS |
|
BP |
GO:0003203 |
endocardial cushion morphogenesis |
The process in which the anatomical structure of the endocardial cushion is generated and organized. The endocardial cushion is a specialized region of mesenchymal cells that will give rise to the heart septa and valves. |
ISS |
|
BP |
GO:0003215 |
cardiac right ventricle morphogenesis |
The process in which the right cardiac ventricle is generated and organized. |
ISS |
|
BP |
GO:0003222 |
ventricular trabecula myocardium morphogenesis |
The process in which the anatomical structures of the trabecular cardiac ventricle muscle are generated and organized. |
ISS |
|
BP |
GO:0003274 |
endocardial cushion fusion |
The cell-cell adhesion process of mesenchymal cardiac cushion cells that contributes to the process of cushion shaping. |
ISS |
|
BP |
GO:0003289 |
atrial septum primum morphogenesis |
The process in which anatomical structure of an atrial septum primum is generated and organized. |
ISS |
|
BP |
GO:0003407 |
neural retina development |
The progression of the neural retina over time from its initial formation to the mature structure. The neural retina is the part of the retina that contains neurons and photoreceptor cells. |
ISS |
|
BP |
GO:0006468 |
protein phosphorylation |
The process of introducing a phosphate group on to a protein. |
IDA |
|
BP |
GO:0007050 |
cell cycle arrest |
A regulatory process that halts progression through the cell cycle during one of the normal phases (G1, S, G2, M). |
IDA |
|
BP |
GO:0007179 |
transforming growth factor beta receptor signaling pathway |
A series of molecular signals initiated by the binding of an extracellular ligand to a transforming growth factor beta receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription. |
IDA |
|
BP |
GO:0007184 |
SMAD protein import into nucleus |
The directed movement of a SMAD proteins from the cytoplasm into the nucleus. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways. |
IDA |
|
BP |
GO:0007267 |
cell-cell signaling |
Any process that mediates the transfer of information from one cell to another. This process includes signal transduction in the receiving cell and, where applicable, release of a ligand and any processes that actively facilitate its transport and presentation to the receiving cell. Examples include signaling via soluble ligands, via cell adhesion molecules and via gap junctions. |
TAS |
|
BP |
GO:0007411 |
axon guidance |
The chemotaxis process that directs the migration of an axon growth cone to a specific target site in response to a combination of attractive and repulsive cues. |
IEA |
|
BP |
GO:0007435 |
salivary gland morphogenesis |
The process in which the anatomical structures of the salivary gland are generated and organized. |
IEP |
|
BP |
GO:0007507 |
heart development |
The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood. |
IDA |
|
BP |
GO:0008219 |
cell death |
Any biological process that results in permanent cessation of all vital functions of a cell. A cell should be considered dead when any one of the following molecular or morphological criteria is met: (1) the cell has lost the integrity of its plasma membrane; (2) the cell, including its nucleus, has undergone complete fragmentation into discrete bodies (frequently referred to as apoptotic bodies). The cell corpse (or its fragments) may be engulfed by an adjacent cell in vivo, but engulfment of whole cells should not be considered a strict criteria to define cell death as, under some circumstances, live engulfed cells can be released from phagosomes (see PMID:18045538). |
IDA |
|
BP |
GO:0008283 |
cell proliferation |
The multiplication or reproduction of cells, resulting in the expansion of a cell population. |
TAS |
|
BP |
GO:0008284 |
positive regulation of cell proliferation |
Any process that activates or increases the rate or extent of cell proliferation. |
IDA |
|
BP |
GO:0008285 |
negative regulation of cell proliferation |
Any process that stops, prevents or reduces the rate or extent of cell proliferation. |
IDA |
|
BP |
GO:0008347 |
glial cell migration |
The orderly movement of a glial cell, non-neuronal cells that provide support and nutrition, maintain homeostasis, form myelin, and participate in signal transmission in the nervous system. |
IDA |
|
BP |
GO:0008584 |
male gonad development |
The process whose specific outcome is the progression of the male gonad over time, from its formation to the mature structure. |
ISS |
|
BP |
GO:0009611 |
response to wounding |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating damage to the organism. |
IEP |
|
BP |
GO:0009790 |
embryo development |
The process whose specific outcome is the progression of an embryo from its formation until the end of its embryonic life stage. The end of the embryonic stage is organism-specific. For example, for mammals, the process would begin with zygote formation and end with birth. For insects, the process would begin at zygote formation and end with larval hatching. For plant zygotic embryos, this would be from zygote formation to the end of seed dormancy. For plant vegetative embryos, this would be from the initial determination of the cell or group of cells to form an embryo until the point when the embryo becomes independent of the parent plant. |
TAS |
|
BP |
GO:0010002 |
cardioblast differentiation |
The process in which a relatively unspecialized mesodermal cell acquires the specialized structural and/or functional features of a cardioblast. A cardioblast is a cardiac precursor cell. It is a cell that has been committed to a cardiac fate, but will undergo more cell division rather than terminally differentiating. |
IDA |
|
BP |
GO:0010628 |
positive regulation of gene expression |
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form. |
IEA |
|
BP |
GO:0010629 |
negative regulation of gene expression |
Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form. |
IEA |
|
BP |
GO:0010634 |
positive regulation of epithelial cell migration |
Any process that activates or increases the frequency, rate or extent of epithelial cell migration. |
IDA |
|
BP |
GO:0010693 |
negative regulation of alkaline phosphatase activity |
Any process that decreases the frequency, rate or extent of alkaline phosphatase activity, the catalysis of the reaction: an orthophosphoric monoester + H2O = an alcohol + phosphate, with an alkaline pH optimum. |
IDA |
|
BP |
GO:0010718 |
positive regulation of epithelial to mesenchymal transition |
Any process that increases the rate, frequency, or extent of epithelial to mesenchymal transition. Epithelial to mesenchymal transition is where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell. |
IDA |
|
BP |
GO:0010862 |
positive regulation of pathway-restricted SMAD protein phosphorylation |
Any process that increases the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways. |
IBA |
|
BP |
GO:0010936 |
negative regulation of macrophage cytokine production |
Any process that decreases the rate, frequency or extent of macrophage cytokine production. Macrophage cytokine production is the appearance of a chemokine due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels. |
IDA |
|
BP |
GO:0014068 |
positive regulation of phosphatidylinositol 3-kinase signaling |
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade. |
IDA |
|
BP |
GO:0016049 |
cell growth |
The process in which a cell irreversibly increases in size over time by accretion and biosynthetic production of matter similar to that already present. |
IEA |
|
BP |
GO:0016477 |
cell migration |
The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues. Cell migration is a central process in the development and maintenance of multicellular organisms. |
IDA |
|
BP |
GO:0023014 |
signal transduction by protein phosphorylation |
A process in which the transfer of one or more phosphate groups to a substrate transmits a signal to the phosphorylated substrate. |
IEA |
|
BP |
GO:0030097 |
hemopoiesis |
The process whose specific outcome is the progression of the myeloid and lymphoid derived organ/tissue systems of the blood and other parts of the body over time, from formation to the mature structure. The site of hemopoiesis is variable during development, but occurs primarily in bone marrow or kidney in many adult vertebrates. |
ISS |
|
BP |
GO:0030199 |
collagen fibril organization |
Any process that determines the size and arrangement of collagen fibrils within an extracellular matrix. |
IDA |
|
BP |
GO:0030307 |
positive regulation of cell growth |
Any process that activates or increases the frequency, rate, extent or direction of cell growth. |
IDA |
|
BP |
GO:0030308 |
negative regulation of cell growth |
Any process that stops, prevents, or reduces the frequency, rate, extent or direction of cell growth. |
IDA |
|
BP |
GO:0030326 |
embryonic limb morphogenesis |
The process, occurring in the embryo, by which the anatomical structures of the limb are generated and organized. A limb is an appendage of an animal used for locomotion or grasping. |
ISS |
|
BP |
GO:0030593 |
neutrophil chemotaxis |
The directed movement of a neutrophil cell, the most numerous polymorphonuclear leukocyte found in the blood, in response to an external stimulus, usually an infection or wounding. |
ISS|TAS |
|
BP |
GO:0031069 |
hair follicle morphogenesis |
The process in which the anatomical structures of the hair follicle are generated and organized. |
ISS |
|
BP |
GO:0032147 |
activation of protein kinase activity |
Any process that initiates the activity of an inactive protein kinase. |
IDA |
|
BP |
GO:0032570 |
response to progesterone |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a progesterone stimulus. |
IDA |
|
BP |
GO:0032874 |
positive regulation of stress-activated MAPK cascade |
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the stress-activated MAPK cascade. |
IDA |
|
BP |
GO:0032909 |
regulation of transforming growth factor beta2 production |
Any process that modulates the frequency, rate, or extent of production of transforming growth factor-beta2. |
IMP |
|
BP |
GO:0032956 |
regulation of actin cytoskeleton organization |
Any process that modulates the frequency, rate or extent of the formation, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising actin filaments and their associated proteins. |
IEA |
|
BP |
GO:0033630 |
positive regulation of cell adhesion mediated by integrin |
Any process that activates or increases the frequency, rate, or extent of cell adhesion mediated by integrin. |
IDA |
|
BP |
GO:0035910 |
ascending aorta morphogenesis |
The process in which the anatomical structures of the ascending aorta are generated and organized. The ascending aorta is the portion of the aorta in a two-pass circulatory system that lies between the heart and the arch of aorta. In a two-pass circulatory system blood passes twice through the heart to supply the body once. |
ISS |
|
BP |
GO:0042060 |
wound healing |
The series of events that restore integrity to a damaged tissue, following an injury. |
ISS |
|
BP |
GO:0042416 |
dopamine biosynthetic process |
The chemical reactions and pathways resulting in the formation of dopamine, a catecholamine neurotransmitter and a metabolic precursor of noradrenaline and adrenaline. |
ISS |
|
BP |
GO:0042476 |
odontogenesis |
The process whose specific outcome is the progression of a tooth or teeth over time, from formation to the mature structure(s). A tooth is any hard bony, calcareous, or chitinous organ found in the mouth or pharynx of an animal and used in procuring or masticating food. |
NAS |
|
BP |
GO:0042493 |
response to drug |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease. |
IDA |
|
BP |
GO:0042637 |
catagen |
The regression phase of the hair cycle during which cell proliferation ceases, the hair follicle shortens, and an anchored club hair is produced. |
IDA |
|
BP |
GO:0042704 |
uterine wall breakdown |
The sloughing of the endometrium and blood vessels during menstruation that results from a drop in progesterone levels. |
TAS |
|
BP |
GO:0043525 |
positive regulation of neuron apoptotic process |
Any process that activates or increases the frequency, rate or extent of cell death of neurons by apoptotic process. |
IDA |
|
BP |
GO:0045216 |
cell-cell junction organization |
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a cell-cell junction. A cell-cell junction is a specialized region of connection between two cells. |
IDA |
|
BP |
GO:0045726 |
positive regulation of integrin biosynthetic process |
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of integrins. |
IDA |
|
BP |
GO:0045778 |
positive regulation of ossification |
Any process that activates or increases the frequency, rate or extent of bone formation. |
IEP |
|
BP |
GO:0045787 |
positive regulation of cell cycle |
Any process that activates or increases the rate or extent of progression through the cell cycle. |
ISS |
|
BP |
GO:0045823 |
positive regulation of heart contraction |
Any process that activates or increases the frequency, rate or extent of heart contraction. |
IDA |
|
BP |
GO:0046580 |
negative regulation of Ras protein signal transduction |
Any process that stops, prevents, or reduces the frequency, rate or extent of Ras protein signal transduction. |
ISS |
|
BP |
GO:0048103 |
somatic stem cell division |
The self-renewing division of a somatic stem cell, a stem cell that can give rise to cell types of the body other than those of the germ-line. |
ISS |
|
BP |
GO:0048566 |
embryonic digestive tract development |
The process whose specific outcome is the progression of the gut over time, from its formation to the mature structure during embryonic development. The gut is the region of the digestive tract extending from the beginning of the intestines to the anus. |
IEP |
|
BP |
GO:0048663 |
neuron fate commitment |
The process in which the developmental fate of a cell becomes restricted such that it will develop into a neuron. |
IEA |
|
BP |
GO:0048666 |
neuron development |
The process whose specific outcome is the progression of a neuron over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell. |
ISS |
|
BP |
GO:0048699 |
generation of neurons |
The process in which nerve cells are generated. This includes the production of neuroblasts and their differentiation into neurons. |
TAS |
|
BP |
GO:0048839 |
inner ear development |
The process whose specific outcome is the progression of the inner ear over time, from its formation to the mature structure. |
ISS |
|
BP |
GO:0050680 |
negative regulation of epithelial cell proliferation |
Any process that stops, prevents or reduces the rate or extent of epithelial cell proliferation. |
IDA|IMP |
|
BP |
GO:0050714 |
positive regulation of protein secretion |
Any process that activates or increases the frequency, rate or extent of the controlled release of a protein from a cell. |
IDA |
|
BP |
GO:0050777 |
negative regulation of immune response |
Any process that stops, prevents, or reduces the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus. |
TAS |
|
BP |
GO:0050778 |
positive regulation of immune response |
Any process that activates or increases the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus. |
ISS |
|
BP |
GO:0051781 |
positive regulation of cell division |
Any process that activates or increases the frequency, rate or extent of cell division. |
IEA |
|
BP |
GO:0051795 |
positive regulation of catagen |
Any process that activates or increases the frequency, rate or extent of catagen, the regression phase of the hair cycle. |
IDA |
|
BP |
GO:0051891 |
positive regulation of cardioblast differentiation |
Any process that activates or increases the frequency, rate or extent of cardioblast differentiation, the process in which a relatively unspecialized mesodermal cell acquires the specialized structural and/or functional features of a cardioblast. A cardioblast is a cardiac precursor cell. It is a cell that has been committed to a cardiac fate, but will undergo more cell division rather than terminally differentiating. |
IDA |
|
BP |
GO:0060021 |
palate development |
The biological process whose specific outcome is the progression of the palate from an initial condition to its mature state. This process begins with the formation of the structure and ends with the mature structure. The palate is the partition that separates the nasal and oral cavities. |
ISS |
|
BP |
GO:0060038 |
cardiac muscle cell proliferation |
The expansion of a cardiac muscle cell population by cell division. |
IDA |
|
BP |
GO:0060065 |
uterus development |
The reproductive developmental process whose specific outcome is the progression of the uterus over time, from its formation to the mature structure. |
ISS |
|
BP |
GO:0060317 |
cardiac epithelial to mesenchymal transition |
A transition where a cardiac epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell. |
IDA |
|
BP |
GO:0060325 |
face morphogenesis |
The process in which the anatomical structures of the face are generated and organized. The face is the ventral division of the head. |
IEA |
|
BP |
GO:0060389 |
pathway-restricted SMAD protein phosphorylation |
The process of introducing a phosphate group on to a pathway restricted SMAD protein. A pathway restricted SMAD protein is an effector protein that acts directly downstream of the transforming growth factor family receptor. |
IDA |
|
BP |
GO:0060395 |
SMAD protein signal transduction |
The cascade of processes by which a signal interacts with a receptor, causing a change in the activity of a SMAD protein, and ultimately effecting a change in the functioning of the cell. |
IBA |
|
BP |
GO:0060412 |
ventricular septum morphogenesis |
The developmental process in which a ventricular septum is generated and organized. A ventricular septum is an anatomical structure that separates the lower chambers (ventricles) of the heart from one another. |
ISS |
|
BP |
GO:0060413 |
atrial septum morphogenesis |
The developmental process in which atrial septum is generated and organized. The atrial septum separates the upper chambers (the atria) of the heart from one another. |
ISS |
|
BP |
GO:0061037 |
negative regulation of cartilage development |
Any process that decreases the rate, frequency, or extent of cartilage development, the process whose specific outcome is the progression of the cartilage over time, from its formation to the mature structure. Cartilage is a connective tissue dominated by extracellular matrix containing collagen type II and large amounts of proteoglycan, particularly chondroitin sulfate. |
IEA |
|
BP |
GO:0061626 |
pharyngeal arch artery morphogenesis |
The process in which the anatomical structures of a pharyngeal arch artery is generated and organized. The pharyngeal arch arteries are a series of six paired embryological vascular structures, the development of which give rise to several major arteries, such as the stapedial artery, the middle meningeal artery, the internal carotid artery and the pulmonary artery. |
ISS |
|
BP |
GO:0070237 |
positive regulation of activation-induced cell death of T cells |
Any process that activates or increases the frequency, rate or extent of activation-induced cell death of T cells. |
IEA |
|
BP |
GO:0090091 |
positive regulation of extracellular matrix disassembly |
Any process that increases the rate, frequency or extent of extracellular matrix disassembly. Extracellular matrix disassembly is a process that results in the breakdown of the extracellular matrix. |
IEA |
|
BP |
GO:0097191 |
extrinsic apoptotic signaling pathway |
A series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with either a ligand binding to a cell surface receptor, or a ligand being withdrawn from a cell surface receptor (e.g. in the case of signaling by dependence receptors), and ends when the execution phase of apoptosis is triggered. |
IDA |
|
BP |
GO:1900182 |
positive regulation of protein localization to nucleus |
Any process that activates or increases the frequency, rate or extent of protein localization to nucleus. |
IEA |
|
BP |
GO:1902256 |
regulation of apoptotic process involved in outflow tract morphogenesis |
Any process that modulates the frequency, rate or extent of apoptotic process involved in outflow tract morphogenesis. |
ISS |
|
BP |
GO:1903701 |
substantia propria of cornea development |
The process whose specific outcome is the progression of a substantia propria of cornea over time, from its formation to the mature structure. |
ISS |
|
BP |
GO:1904426 |
positive regulation of GTP binding |
Any process that activates or increases the frequency, rate or extent of GTP binding. |
IEA |
|
BP |
GO:1904888 |
cranial skeletal system development |
The process whose specific outcome is the progression of a cranial skeletal system over time, from its formation to the mature structure. The cranial skeletal system is the skeletal subdivision of the head, and includes the skull (cranium plus mandible), pharyngeal and/or hyoid apparatus. |
ISS |
|
BP |
GO:1905006 |
negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation |
Any process that stops, prevents or reduces the frequency, rate or extent of epithelial to mesenchymal transition involved in endocardial cushion formation. |
ISS |
|
BP |
GO:1905007 |
positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation |
Any process that activates or increases the frequency, rate or extent of epithelial to mesenchymal transition involved in endocardial cushion formation. |
ISS |
|
BP |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand |
Any process that activates or increases the frequency, rate or extent of extrinsic apoptotic signaling pathway in absence of ligand. |
IEA |
|
CC |
GO:0005576 |
extracellular region |
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. |
IDA|TAS |
|
CC |
GO:0005615 |
extracellular space |
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
IDA |
|
CC |
GO:0005768 |
endosome |
A vacuole to which materials ingested by endocytosis are delivered. |
IEA |
|
CC |
GO:0030424 |
axon |
The long process of a neuron that conducts nerve impulses, usually away from the cell body to the terminals and varicosities, which are sites of storage and release of neurotransmitter. |
ISS |
|
CC |
GO:0031012 |
extracellular matrix |
A structure lying external to one or more cells, which provides structural support for cells or tissues. |
IDA |
|
CC |
GO:0031093 |
platelet alpha granule lumen |
The volume enclosed by the membrane of the platelet alpha granule. |
TAS |
|
CC |
GO:0043025 |
neuronal cell body |
The portion of a neuron that includes the nucleus, but excludes cell projections such as axons and dendrites. |
ISS |
|
MF |
GO:0001540 |
beta-amyloid binding |
Interacting selectively and non-covalently with beta-amyloid peptide/protein and/or its precursor. |
IDA |
|
MF |
GO:0004702 |
receptor signaling protein serine/threonine kinase activity |
Conveys a signal from an upstream receptor or intracellular signal transducer by catalysis of the reaction: ATP protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate. |
IDA |
|
MF |
GO:0005102 |
receptor binding |
Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function. |
IMP |
|
MF |
GO:0005114 |
type II transforming growth factor beta receptor binding |
Interacting selectively and non-covalently with a type II transforming growth factor beta receptor. |
IDA|IMP|IPI |
|
MF |
GO:0005125 |
cytokine activity |
Functions to control the survival, growth, differentiation and effector function of tissues and cells. |
TAS |
|
MF |
GO:0005160 |
transforming growth factor beta receptor binding |
Interacting selectively and non-covalently with the transforming growth factor beta receptor. |
IDA |
|
MF |
GO:0005515 |
protein binding |
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
IPI |
|
MF |
GO:0008083 |
growth factor activity |
The function that stimulates a cell to grow or proliferate. Most growth factors have other actions besides the induction of cell growth or proliferation. |
IEA |
|
MF |
GO:0034714 |
type III transforming growth factor beta receptor binding |
Interacting selectively and non-covalently with a type III transforming growth factor beta receptor. |
IMP|IPI |
|
MF |
GO:0042803 |
protein homodimerization activity |
Interacting selectively and non-covalently with an identical protein to form a homodimer. |
IDA |
|
MF |
GO:0046982 |
protein heterodimerization activity |
Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer. |
TAS |
| Domain ID | Description |
|---|---|
|
IPR001111 |
TGF-beta, propeptide |
|
IPR001839 |
Transforming growth factor-beta, C-terminal |
|
IPR003940 |
Transforming growth factor, beta 2 |
|
IPR015615 |
Transforming growth factor-beta-related |
|
IPR016319 |
Transforming growth factor-beta |
|
IPR017948 |
Transforming growth factor beta, conserved site |
|
IPR029034 |
Cystine-knot cytokine |
| Pathway ID | Pathway Term | Pathway Source |
|---|---|---|
|
hsa04010 |
MAPK signaling pathway |
KEGG |
|
hsa04060 |
Cytokine-cytokine receptor interaction |
KEGG |
|
hsa04068 |
FoxO signaling pathway |
KEGG |
|
hsa04110 |
Cell cycle |
KEGG |
|
hsa04144 |
Endocytosis |
KEGG |
|
hsa04350 |
TGF-beta signaling pathway |
KEGG |
|
hsa04380 |
Osteoclast differentiation |
KEGG |
|
hsa04390 |
Hippo signaling pathway |
KEGG |
|
hsa04933 |
AGE-RAGE signaling pathway in diabetic complications |
KEGG |
|
hsa05140 |
Leishmaniasis |
KEGG |
|
hsa05142 |
Chagas disease (American trypanosomiasis) |
KEGG |
|
hsa05144 |
Malaria |
KEGG |
|
hsa05145 |
Toxoplasmosis |
KEGG |
|
hsa05146 |
Amoebiasis |
KEGG |
|
hsa05152 |
Tuberculosis |
KEGG |
|
hsa05161 |
Hepatitis B |
KEGG |
|
hsa05166 |
HTLV-I infection |
KEGG |
|
hsa05200 |
Pathways in cancer |
KEGG |
|
hsa05205 |
Proteoglycans in cancer |
KEGG |
|
hsa05206 |
MicroRNAs in cancer |
KEGG |
|
hsa05210 |
Colorectal cancer |
KEGG |
|
hsa05211 |
Renal cell carcinoma |
KEGG |
|
hsa05212 |
Pancreatic cancer |
KEGG |
|
hsa05220 |
Chronic myeloid leukemia |
KEGG |
|
hsa05321 |
Inflammatory bowel disease (IBD) |
KEGG |
|
hsa05323 |
Rheumatoid arthritis |
KEGG |
|
hsa05410 |
Hypertrophic cardiomyopathy (HCM) |
KEGG |
|
hsa05414 |
Dilated cardiomyopathy |
KEGG |
|
WP2884 |
NRF2 pathway |
WikiPathways |
|
WP2870 |
Extracellular vesicle-mediated signaling in recipient cells |
WikiPathways |
|
WP382 |
MAPK Signaling Pathway |
WikiPathways |
|
WP474 |
Endochondral Ossification |
WikiPathways |
|
WP400 |
p38 MAPK Signaling Pathway |
WikiPathways |
|
h_alkPathway |
ALK in cardiac myocytes |
BioCarta |
|
h_g1Pathway |
Cell Cycle: G1/S Check Point |
BioCarta |
|
h_ctcfPathway |
CTCF: First Multivalent Nuclear Factor |
BioCarta |
|
h_inflamPathway |
Cytokines and Inflammatory Response |
BioCarta |
|
h_erythPathway |
Erythrocyte Differentiation Pathway |
BioCarta |
|
h_slrp2Pathway |
Function of SLRP in Bone: An Integrated View |
BioCarta |
|
h_mapkPathway |
MAPKinase Signaling Pathway |
BioCarta |
|
h_p38mapkPathway |
p38 MAPK Signaling Pathway |
BioCarta |
|
h_tob1Pathway |
Role of Tob in T-cell activation |
BioCarta |
|
h_nktPathway |
Selective expression of chemokine receptors during T-cell polarization |
BioCarta |
|
h_il1rPathway |
Signal transduction through IL1R |
BioCarta |
|
h_tgfbPathway |
TGF beta signaling pathway |
BioCarta |
| UMLS CUI | UMLS Term |
|---|---|
|
C0003504 |
Aortic Valve Insufficiency |
|
C0005941 |
Bone Diseases, Developmental |
|
C0008925 |
Cleft Palate |
|
C0010520 |
Cyanosis |
|
C0014175 |
Endometriosis |
|
C0015393 |
Eye Abnormalities |
|
C0017601 |
Glaucoma |
|
C0018798 |
Congenital Heart Defects |
|
C0024117 |
Chronic Obstructive Airway Disease |
|
C0035238 |
Congenital Abnormality Of Respiratory System |
|
C0041956 |
Ureteral Obstruction |
|
C0042063 |
Urogenital Abnormalities |
|
C0151491 |
Congenital Musculoskeletal Anomalies |
|
C0162872 |
Aortic Aneurysm, Thoracic |
|
C0206762 |
Limb Deformities, Congenital |
|
C0376634 |
Craniofacial Abnormalities |
|
C2697932 |
Loeys-Dietz Syndrome |
| Database Name |
|---|
|
DGA |
| Pubmed ID | Author | Year | Title |
|---|---|---|---|
|
22617121 |
Ouandaogo et al. |
2012 |
Differences in transcriptomic profiles of human cumulus cells isolated from oocytes at GV, MI and MII stages after in vivo andin vitro oocyte maturation |
|
23824412 |
Piltonen et al. |
2013 |
Mesenchymal Stem/Progenitors and Other Endometrial Cell Types From Women With Polycystic Ovary Syndrome (PCOS) Display Inflammatory and Oncogenic Potential |
| Gene Symbol | Entrez ID | Uniprot ID | Score |
|---|---|---|---|
|
CTGF |
1490 |
P29279 |
0.52 |
|
TGFB2 |
7042 |
P61812 |
0.52 |
|
ENG |
2022 |
P17813 |
0.55 |
|
TGFBR1 |
7046 |
P36897 |
0.62 |
|
BMP2 |
650 |
P12643 |
0.65 |
|
TGFBRAP1 |
9392 |
Q8WUH2 |
0.72 |
|
DAXX |
1616 |
Q9UER7 |
0.75 |
|
DCN |
1634 |
P07585 |
0.75 |
|
TGFB1 |
7040 |
P01137 |
0.75 |
|
TGFBR2 |
7048 |
P37173 |
0.84 |
|
APP |
351 |
P05067 |
0.87 |
|
FMOD |
2331 |
Q06828 |
0.52 |
|
LTBP3 |
4054 |
Q9NS15 |
0.52 |
|
TGFB3 |
7043 |
P10600 |
0.52 |
|
CEBPA |
1050 |
P49715 |
0.63 |
|
PZP |
5858 |
P20742 |
0.75 |
|
VTN |
7448 |
P04004 |
0.75 |
|
VASN |
114990 |
Q6EMK4 |
0.75 |
|
TGFBR3 |
7049 |
Q03167 |
0.76 |